EM 5
Pill imprint EM 5 has been identified as Methimazole 5 mg.
Methimazole is used in the treatment of hyperthyroidism and belongs to the drug class antithyroid agents. There is positive evidence of human fetal risk during pregnancy.
Methimazole 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Methimazole Images
- Imprint:
-
EM 5
- Strength:
- 5 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
magnesium stearate
corn starch
magnesium silicate
- Drug Class:
- Antithyroid agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- 49884-0640
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-6071 | Physicians Total Care Inc (repackager) |
| 55045-3455 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More Methimazole resources
- Methimazole (Wolters Kluwer)
- methimazole (Cerner Multum)
- methimazole (Micromedex) - Includes Dosage Information
- Methimazole (AHFS DI)
- Felimazole (FDA)
- Methimazole (FDA)
- Methimazole (Wolters Kluwer)


